Outline* The shown information is the one as of the awarded date and might has been changed.
SMAiLEE realizes more efficient medical communication between spinal muscular atrophy(SMA) patients and health care professionals by recording and sharing the motor function of patients at home. SMA is the intractable rare disease that is marked by progressive, debilitating muscle weakness. There was no medical treatment before nusinersen had arrroved in 2017. In SMA treatment, it is important to assess the motor function of patients accurately, but especially in infants, sometimes it is difficult because of their mood and physical condition at the examination room. So, we aimed to improve the treatment environment by providing an application that can easily record and share the motor functions which are useful for the treatment assessment.
Yukiko Katayama, Product Manager, Rare Disease (SMA) Business Unit, Biogen Japan, Ltd.
Manabu Nakano Product Development Div Product Designer Welby Inc.
Saori Ishizu Product Development Div Product Designer Welby Inc.
- More information
- Already in service/use